Back to MORGAN STANLEY MORGAN STANLEY

RGNXRGNX
8 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in REGENXBIO INC

MORGAN STANLEY holds 2.1M shares of RGNX (REGENXBIO INC), worth $17.3M as of 2026-Q1. The position was increased (+2.5% shares). RGNX represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$17.3M

Current Shares

2.1M

Total Value Change

+$3.5M

Total Shares Change

+886,305

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
2.1M
+2.5%
$17.3M0.0%$8.69
29
2025-Q4
Increased
2M
+18.2%
$29M0.0%$14.09
34
2025-Q3
Increased
1.7M
+71.3%
$16.4M0.0%$9.85
42
2025-Q2
Decreased
994,756
-51.9%
$8.2M0.0%$8.39
0
2025-Q1
Increased
2.1M
+3.2%
$14.8M0.0%$7.83
29
2024-Q4
Increased
2M
+48.4%
$15.5M0.0%$7.23
39
2024-Q3
Increased
1.3M
+14.4%
$14.2M0.0%$10.80
32
2024-Q2
New
1.2M
-
$13.8M0.0%$11.70
39

Other major holders of RGNX: BlackRock Finance, Inc., BlackRock, Inc., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used